Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Dapagliflozin
81%
Patient
81%
Glucose
77%
Cells
65%
Therapeutic Procedure
59%
Adipocyte
55%
Plasma
46%
Insulin
43%
Gluconeogenesis
42%
Combination Therapy
42%
Insulin Resistance
39%
Inpatient
38%
Adipose Tissue
38%
Placebo
38%
Obesity
35%
Insulin Sensitivity
34%
Adiponectin
31%
Glucagon-Like Peptide-1 Agonist
29%
Leptin
29%
Insulin Release
28%
Connexin 43
27%
Patient with Type 2 Diabetes
24%
Glucosuria
24%
Exenatide
21%
Bone
20%
Cardiovascular Disease
20%
Gap Junction Protein
20%
Pioglitazone
19%
Heart
19%
Chronic Kidney Disease
19%
Cell Function
19%
Cardiovascular System
19%
Hyperglycemia
19%
Tissues
18%
Glucose Uptake
18%
Glucagon
18%
Cancer
17%
Glycemic Control
17%
Body Weight
16%
Paget's Disease
16%
Diabetes
16%
Lipid Diet
16%
Type 2 Diabetes
16%
Development
16%
Osteocyte
15%
Regulatory Mechanism
15%
Glucose Tolerance
15%
Lifespan
15%
Clinical Trial
15%
Osteoclast
15%
Sarcopenia
14%
Oral Glucose Tolerance Test
14%
White Adipose Tissue
13%
Finerenone
13%
Heart Function
13%
Musculoskeletal Health
12%
Glucagon Like Peptide 1
12%
Mineralocorticoid Antagonist
12%
Kidney
12%
Hypercalcaemia
12%
Serositis
12%
Antidiabetic Agent
12%
Fine-Needle Aspiration
11%
Adverse Event
11%
Gene
11%
Cotransporter
11%
Weight Loss
11%
Hyperleptinemia
11%
Cell Communication
11%
Fat
10%
Hypoglycemia
10%
Health Outcomes
10%
Resistance Training
10%
Diabetes Mellitus
10%
Male
10%
Metabolism
10%
Chemotherapeutic Agent
9%
Drug
9%
Empagliflozin
9%
Creatine Phosphate
9%
Pheochromocytoma
9%
Iron
9%
Cannabinoid 1 Receptor
9%
Vascular Disease
9%
Osteoclast Differentiation Factor
9%
Hepatocyte Nuclear Factor 4
9%
Peroxisome Proliferator Activated Receptor
9%
Gonadorelin Agonist
9%
Calcium Excretion
9%
Primary Hyperparathyroidism
9%
Patient with Type 1 Diabetes
9%
Semaglutide
9%
Human Study
9%
Physical Activity
9%
Meta-Analysis
9%
Placebo
9%
Absorptiometry
9%
Microinjection
9%
Infusion
9%
Biochemistry, Genetics and Molecular Biology
Connexin
58%
Mouse
55%
Adipocyte
47%
Glucose
37%
Osteocyte
21%
Insulin Release
20%
Chicken
19%
Fat
17%
Knockout Mouse
17%
Dapagliflozin
15%
Lipid Metabolism
15%
Gluconeogenesis
14%
Vascularization
13%
Insulin Resistance
13%
Lipogenesis
13%
Adiponectin
12%
Free Fatty Acids
12%
Ossification
11%
Peptide
11%
Wound Healing
11%
Hyaluronan
9%
Galactose
9%
Pyruvate Kinase
9%
Iron
9%
Dimethyl Sulfoxide
9%
Lipid Droplet
9%
Bile Acid Synthesis
9%
Bile Acid
9%
Syntaxin
9%
Hepatocyte Nuclear Factor 4
9%
Calcium Excretion
9%
Calcium Urine Level
9%
Human Study
9%
Physical Activity
9%
Adenosine Triphosphate
9%
Prostaglandin E2
9%
Titer
9%
Prostaglandin E2
9%
Marker Gene
9%
Microinjection
9%
Mitochondrial Respiration
9%
Retrovirus
9%
Stromal Cell
9%
Arginine
9%
Alternative Splicing
9%
Serine
9%
Protein Kinase
9%
Hepatic Stellate Cell
9%
Acetyl-CoA Synthetase
9%
Peroxisome Proliferator-Activated Receptor Gamma
9%
Drug Efficacy
9%
Lifespan
9%
Insulin
9%
Nested Gene
9%
Metabolic Pathway
8%
Electric Potential
8%
Glucose Blood Level
8%
Osteolysis
8%
Excretion
8%
FGF21
7%
Glucose Metabolism
7%
Mouse Model
7%
Development
7%
Lysozyme
7%
Lipolysis
6%
Regulatory Mechanism
6%
Immunity
6%
Apoptosis
6%
Cotransporter
6%
Transmembrane Protein
6%
Glucose Homeostasis
5%
Phenotype
5%
Lipid
5%
Pressure
5%
Ossification
5%
Insulin Sensitivity
5%
Protein
5%
Drive
5%
Transgenic Mouse
5%
Cancer Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
31%
Leptin
29%
Mouse
21%
Semaglutide
19%
Pioglitazone
19%
Gap Junction Protein
19%
Adiponectin
18%
Dapagliflozin
17%
Obesity
15%
Insulin Resistance
14%
Glucose
11%
Insulin
10%
Vascular Disease
9%
Liraglutide
9%
Bile Acid
9%
Dimethyl Sulfoxide
9%
Liver Injury
9%
Prasterone
9%
Semaglutide
9%
Linagliptin
9%
Empagliflozin
9%
Hepatocyte Nuclear Factor 4
9%
Nonalcoholic Fatty Liver
9%
Peroxisome Proliferator Activated Receptor
9%
Muscone
9%
Primary Hyperparathyroidism
9%
Hyperleptinemia
9%
Placebo
9%
Glucagon Like Peptide 1 Receptor Agonist
9%
Connexin 43
9%
Breast Cancer
9%
Diseases
9%
Osteosarcoma
9%
Adenosine Triphosphate
9%
Amyloid Protein
9%
Alzheimer's Disease
9%
Synthetase
9%
Acetate Coenzyme A Ligase
9%
Glitazone Derivative
8%
Drug
7%
Antidiabetic Agent
7%
Adverse Event
7%
Diseases
6%
Placebo
6%
Diethylstilbestrol
6%
Osteoporosis
5%
Metastasis
5%
Leptin Deficiency
5%
Estrogen
5%
Luciferase
5%
Hyperglycemia
5%
Saxagliptin
5%